AFLAC Incorporated vs Cassava Sciences Inc — how do they compare? AFLAC Incorporated trades at $121.06 (market cap $61.13B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: AFLAC Incorporated is far larger — about 1280.2× Cassava Sciences Inc's market cap, and AFLAC Incorporated pays a 2% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| AFL | FLNA | |
|---|---|---|
Market Cap | $61.13B | $47.75M |
Sector | Financials | Health |
52-Week High | $129.55 | $4.64 |
52-Week Low | $103.55 | $0.87 |
Enterprise Value | $71.08B | -$34.93M |
Dividend Yield | 2% | — |
Trailing returns across standard periods
Latest headlines on both assets
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →